Winston Pharmaceuticals
Vernon Hills
About Winston Pharmaceuticals
Winston is a pharmaceutical company focused on developing pain management products for large pain-control markets, as well as on niche markets, where there are still significant needs for pain management options with improved efficacy, safety, and tolerability profiles. Winston’s late-stage product candidates span a range of pain indications, including episodic cluster headache, migraine and tension headache, osteo- and rheumatoid arthritis, neuropathic pain, cancer pain and pain associated with inflammatory bowel disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $375.0K
- Funding stage: IPO
- Last round: Grant (Apr 2012)
- Ticker: otcpink:WPHM
- Website: winstonlabs.com
- Phone: 8473628394
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/winston-pharmaceuticals-2257233 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.